Results 1 to 10 of about 4,346,476 (378)

Intrauterine contraceptive devices. [PDF]

BMJ, 1966
In recent years the intrauterine contraceptive device has been recognized as an important means of family planning and population control. Its effectiveness exceeds that of traditional contraceptive methods but is less than that of oral contraceptives. The exact mechanism of contraception with the intrauterine device remains unknown.
M. R. Neely
  +13 more sources

The Intrauterine Contraceptive Device [PDF]

Proceedings of the Royal Society of Medicine, 1967
The first section in these proceedings discusses clinical experience with IUDs by 1966 in clinic patients. There were 1194 fittings and 1028 "woman years" of use; 44 pregnancies and 2 ectopic pregnancies occurred in 1028 women with 25 pregnancies occurring with the IUD in place. There were 23 terminations of these pregnancies; 3 pregnancies continued
Charles H. Birnberg
openalex   +5 more sources

Intrauterine devices and risk of uterine perforation: current perspectives [PDF]

Open Access Journal of Contraception, 2016
Sam Rowlands,1 Emeka Oloto,2 David H Horwell3 1Centre of Postgraduate Medical Research and Education, Faculty of Health and Social Sciences, Bournemouth University, Dorset, UK; 2Staffordshire and Stoke on Trent Partnership NHS Trust, Leicester, UK ...
Rowlands S, Oloto E, Horwell DH
doaj   +3 more sources

Intrauterine Contraceptive Devices [PDF]

BMJ, 1965
Hugh Corbett
  +13 more sources

The rolling stone: migration of an intrauterine device leading to bladder stone formation nine years after insertion: a case report [PDF]

BMC Urology
Background Intrauterine devices are safe, affordable, convenient, and the most common form of contraception used by females of childbearing age in Palestine.
Elie G. Malki, Dina Sbeih, Peter Bael, Haitham Alsarabta, Ahmad Alzawahra   +4 more
doaj   +2 more sources

Treatment of unacceptable bleeding in long-term users of 52-mg levonorgestrel intrauterine device: a prospective observational studyAJOG Global Reports at a Glance [PDF]

AJOG Global Reports
BACKGROUND: In the first month after the insertion of the 52-mg levonorgestrel intrauterine device, irregular vaginal bleeding often occurs. In 6% to 18% of 52-mg levonorgestrel intrauterine device users, irregular vaginal bleeding reoccurs or continues ...
Patty A.H.H. van der Heijden, MD, Karlijn A. Röttgering, Tamara J. Oderkerk, MD, Jeanne P. Dieleman, Arianne C. Lim, PhD, Marlies Y. Bongers, PhD, Peggy M.A.J. Geomini, PhD   +6 more
doaj   +2 more sources

Risk factors for postpartum intrauterine device expulsion among women delivering at a tertiary Hospital in Uganda: a prospective cohort study

Contraception and Reproductive Medicine, 2021
Background Postpartum intrauterine device (PPIUD) use refers to intrauterine device (IUD) insertion after delivery but within 48 h of birth. In Uganda, the general use of modern methods of contraception is low with
Joy Muhumuza, Richard Migisha, Joseph Ngonzi, Musa Kayondo, Godfrey Mugyenyi   +4 more
doaj   +1 more source

Evaluation of postpartum intrauterine contraceptive device in terms of awareness, acceptance and expulsion

Journal of Medical and Scientific Research, 2022
Introduction: Immediate postpartum period is when women are receptive to family planning counselling. Pregnancy within a year of the last delivery increases maternal and perinatal morbidity and mortality.
Bahadur BR, Kodey P, Katari N
doaj   +1 more source

Trends of intrauterine device insertion and ‘Googling’ about intrauterine devices before and during the COVID-19 pandemic in Australia

Digital Health, 2022
Objective The COVID-19 pandemic significantly disrupted access to primary care in Australia. This could have negatively impacted reproductive health services rates such as intrauterine device insertion rates, and interest in seeking information about ...
Sarah D’Arcy, Chester Cao, Steve Ahn, Victoria Allan, Alireza Ahmadvand   +4 more
doaj   +1 more source

Safety profile of immediate post-partum intrauterine device insertion during caesarean delivery – a clinical trial with three years of follow up

مجله كليه طب الكندي, 2022
Background: Many countries recommend the use of long-acting reversible contraceptive intrauterine device immediately after cesarean delivery. The cesarean delivery rate in Iraqi public hospitals is 32.2% and may reach 85.8% in private hospitals ...
Taghreed Alhaidari, Asmma Majeed , Sahar Al-Jassani , Hayder Fawzi , Lewai ‎ Abdulaziz , Faysal El Kak   +5 more
doaj   +1 more source